Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 3/2021

01-07-2021 | Epstein-Barr Virus | Original Article

Epstein–Barr Virus Expression in Classic Hodgkin Lymphoma in an Indian Cohort and its Association with Clinical and Histomorphological Parameters

Authors: Preeti Rani, Mili Jain, Nishant Verma, Archana Kumar, Amita Jain, Anil Kumar Tripathi, Ashutosh Kumar

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2021

Login to get access

Abstract

Epstein Barr virus (EBV) associated Hodgkin lymphoma (HL) has been defined as cases with clonal EBV infection, EBV genome and gene products in the Reed Sternberg cells. We evaluated the prevalence and clinico-pathological association of EBV in North Indian HL patients. Eighty-eight cases of histologically confirmed classic HL were evaluated for EBV by both IHC expression of LMP1 and real time PCR on formalin fixed lymph node tissue. The expression pattern was analyzed for any association with clinical and histomorphological parameters. Nodular sclerosis subtype was seen in 79.5% patients and mixed cellularity was seen in the remaining patients. Ninety percent of the cases were positive for EBV. The detection rate of EBV by IHC was higher. The EBV positive cases presented with higher disease stage (p < 0.05). The presence of histomorphological features like granuloma formation (5/5), atypical lymphocytes (8/8), histiocyte clusters (26/28), large area of necrosis (11/12), less prominent inflammatory response (25/27) was associated with EBV positivity (p > 0.05). In our study population a high proportion of HL cases showed positivity for EBV indicating a pathogenic role. The positivity was independent of age, gender and histological subtype. Further evaluation of EBV positivity in modulation of tumor immunity may provide insights into variable treatment outcome in EBV positive cases.
Literature
1.
go back to reference Gandhi MK, Lambley E, Burrows J, Dua U, EllioT S, Shaw PJ, Prince HM, Wolf M, Clarke K, Underhill C, Mills T, Mollee P, Gill D, Marlon P, Seymour JF, Khanna R (2006) Plasma Epstein–Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin’s lymphoma. Clin Cancer Res 12:460–464CrossRef Gandhi MK, Lambley E, Burrows J, Dua U, EllioT S, Shaw PJ, Prince HM, Wolf M, Clarke K, Underhill C, Mills T, Mollee P, Gill D, Marlon P, Seymour JF, Khanna R (2006) Plasma Epstein–Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin’s lymphoma. Clin Cancer Res 12:460–464CrossRef
2.
go back to reference Jarrett RF (2003) Risk factors for Hodgkin’s Lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV- associated Hodgkin’s Lymphoma. Leuk Lymphoma 44(Suppl 3):S27–S32CrossRef Jarrett RF (2003) Risk factors for Hodgkin’s Lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV- associated Hodgkin’s Lymphoma. Leuk Lymphoma 44(Suppl 3):S27–S32CrossRef
3.
go back to reference Flavell KJ, Murray PG (2000) Hodgkin’s disease and the Epstein–Barr virus. Mol Pathol 53(5):262–269CrossRef Flavell KJ, Murray PG (2000) Hodgkin’s disease and the Epstein–Barr virus. Mol Pathol 53(5):262–269CrossRef
4.
go back to reference Dinanad V, Dawar R, Arya S, Unni R, Mohanty B, Singh R (2007) Hodgkin’s lymphoma in Indian children: prevalence and significance of Epstein–Barr virus detection in Hodgkin’s and Reed-Sternberg cells. Eur J Cancer 43(1):161–168CrossRef Dinanad V, Dawar R, Arya S, Unni R, Mohanty B, Singh R (2007) Hodgkin’s lymphoma in Indian children: prevalence and significance of Epstein–Barr virus detection in Hodgkin’s and Reed-Sternberg cells. Eur J Cancer 43(1):161–168CrossRef
5.
go back to reference Qi ZL, Han XQ, Hu J, Wang GH, Gao JW, Wang X, Liang DY (2013) Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin’s lymphoma in paraffin-embedded tissues. Mol Med Rep 7:89–92CrossRef Qi ZL, Han XQ, Hu J, Wang GH, Gao JW, Wang X, Liang DY (2013) Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin’s lymphoma in paraffin-embedded tissues. Mol Med Rep 7:89–92CrossRef
7.
go back to reference Wasielewski SV, Franklin J, Fischer R, Hubner K, Hansmann ML, Diehl V, Georgii A, Wasielewski RV (2002) Nodular sclerosing Hodgkin’s disease: new grading predicts prognosis in intermediate and advanced stages. Blood 05:1548 Wasielewski SV, Franklin J, Fischer R, Hubner K, Hansmann ML, Diehl V, Georgii A, Wasielewski RV (2002) Nodular sclerosing Hodgkin’s disease: new grading predicts prognosis in intermediate and advanced stages. Blood 05:1548
8.
go back to reference Rhodes A (2013) Fixation of tissues. Bancroft’s theory and practice of histological techniques, 7th edn. Elsevier, Amsterdam, pp 69–94CrossRef Rhodes A (2013) Fixation of tissues. Bancroft’s theory and practice of histological techniques, 7th edn. Elsevier, Amsterdam, pp 69–94CrossRef
9.
go back to reference Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C (2003) Expression of Epstein–Barr virus latent membrane protein-1 in Hodgkin and Reed–Sternberg cells of classical Hodgkin’s lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 9(6):2114–2120PubMed Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C (2003) Expression of Epstein–Barr virus latent membrane protein-1 in Hodgkin and Reed–Sternberg cells of classical Hodgkin’s lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 9(6):2114–2120PubMed
10.
go back to reference Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD (2000) Development of a real-time quantitative assay for detection of Epstein–Barr virus. J Clin Microbiol 38:712–715CrossRef Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD (2000) Development of a real-time quantitative assay for detection of Epstein–Barr virus. J Clin Microbiol 38:712–715CrossRef
11.
go back to reference Prakash S, Jain A, Jain B (2016) Development of novel triplex single-step real-time PCR assay for detection of Hepatitis Virus B and C simultaneously. Virology 31(492):101–107CrossRef Prakash S, Jain A, Jain B (2016) Development of novel triplex single-step real-time PCR assay for detection of Hepatitis Virus B and C simultaneously. Virology 31(492):101–107CrossRef
12.
go back to reference Dinand V, Sachdeva A, Datta S, Bhalla S, Kalara M, Wattal C, Radhakrishnan N (2015) Plasma Epstein–Barr Virus(EBV) DNA as a biomarker for EBV-associated Hodgkin Lymphoma. Indian Paediatr 52:681–685CrossRef Dinand V, Sachdeva A, Datta S, Bhalla S, Kalara M, Wattal C, Radhakrishnan N (2015) Plasma Epstein–Barr Virus(EBV) DNA as a biomarker for EBV-associated Hodgkin Lymphoma. Indian Paediatr 52:681–685CrossRef
13.
go back to reference Naresh KN, Johnson J, Srinivas V, Soman CS, Saikia T, Advani SH, Badwe RA, Dinshaw KA, Muckaden M, Magrath I, Bhatia K (2001) Epstein-Barr virus association in classical Hodgkin’s disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 11(1):91–96CrossRef Naresh KN, Johnson J, Srinivas V, Soman CS, Saikia T, Advani SH, Badwe RA, Dinshaw KA, Muckaden M, Magrath I, Bhatia K (2001) Epstein-Barr virus association in classical Hodgkin’s disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 11(1):91–96CrossRef
14.
go back to reference Karnik S, Srinivasan B, Nair S (2003) Hodgkin’s Lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital. Pathology 35:207–211CrossRef Karnik S, Srinivasan B, Nair S (2003) Hodgkin’s Lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital. Pathology 35:207–211CrossRef
15.
go back to reference Gandhi MK, Tellam JT, Khanna R (2004) Epstein–Barr virus-associated Hodgkin’s lymphoma. Br J Haematol 125(3):267–281CrossRef Gandhi MK, Tellam JT, Khanna R (2004) Epstein–Barr virus-associated Hodgkin’s lymphoma. Br J Haematol 125(3):267–281CrossRef
16.
go back to reference Lingyun G, Xin W (2015) Epstein–Barr virus-associated lymphoproliferative disorders: experimental and clinical developments. Int J Clin Exp Med 8(9):14656–14671 Lingyun G, Xin W (2015) Epstein–Barr virus-associated lymphoproliferative disorders: experimental and clinical developments. Int J Clin Exp Med 8(9):14656–14671
17.
go back to reference Skinnider BF, Mak TW (2002) The role of cytokines in classical Hodgkin lymphoma. Blood 99(12):4283–4297CrossRef Skinnider BF, Mak TW (2002) The role of cytokines in classical Hodgkin lymphoma. Blood 99(12):4283–4297CrossRef
18.
go back to reference Ramos-Vara JA (2011) Principles and methods of immunohistochemistry. Methods Mol Biol 691:83–96CrossRef Ramos-Vara JA (2011) Principles and methods of immunohistochemistry. Methods Mol Biol 691:83–96CrossRef
Metadata
Title
Epstein–Barr Virus Expression in Classic Hodgkin Lymphoma in an Indian Cohort and its Association with Clinical and Histomorphological Parameters
Authors
Preeti Rani
Mili Jain
Nishant Verma
Archana Kumar
Amita Jain
Anil Kumar Tripathi
Ashutosh Kumar
Publication date
01-07-2021
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01359-9

Other articles of this Issue 3/2021

Indian Journal of Hematology and Blood Transfusion 3/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine